| 3D | three-dimensional |
| ABS | American Brachytherapy Society |
| BT | brachytherapy |
| CI | confidence interval |
| COIN | conformity index |
| CT | computed tomography |
| CTCAE | Common Terminology Criteria for Adverse Events |
| DHI | dose homogeneity index |
| DMFS | distant metastasis-free survival |
| DVH | dose–volume histogram |
| EBRT | external beam radiotherapy |
| EQD2 | equivalent dose in 2-Gy fractions |
| FIGO | International Federation of Gynecology and Obstetrics |
| GEC-ESTRO | Groupe Européen de Curiethérapie–European Society for Radiotherapy and Oncology |
| GI | gastrointestinal |
| GTV | gross tumor volume |
| GU | genitourinary |
| HDR | high-dose-rate |
| HR | hazard ratio |
| HR-CTV | high-risk clinical target volume |
| IC/IS | intracavitary–interstitial |
| ICRU | International Commission on Radiation Units and Measurements |
| IGABT | image-guided adaptive brachytherapy |
| IMRT | intensity-modulated radiotherapy |
| IQR | interquartile range |
| LACC | locally advanced cervical cancer |
| LRFS | local recurrence-free survival |
| MRI | magnetic resonance imaging |
| OAR | organ at risk |
| OS | overall survival |
| OTT | overall treatment time |
| PFS | progression-free survival |
| PLA | polylactic acid |
| RCS | restricted cubic spline |
| ROC | receiver operating characteristic |
| RRFS | regional recurrence-free survival |
| SIB | simultaneous integrated boost |
| VMAT | volumetric modulated arc therapy |